At a glance
- Originator Amura; Micron Research
- Class Antibacterials; Oxapenems
- Mechanism of Action Beta lactamase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 25 Aug 2006 Discontinued - Preclinical for Bacterial infections in United Kingdom (unspecified route)
- 31 Dec 2002 Data presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2002) have been added to the Bacterial Infections pharmacodynamics section
- 16 Jul 2002 Preclinical trials in Bacterial infections in United Kingdom (unspecified route)